Module 5: Maximizing the Controlled Substances Agreement
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Module 5: Maximizing the Controlled Substances Agreement
-
Narrated by:
-
Written by:
About this listen
This week’s case is about David, who is a 65- year-old male with chronic pain from severe degenerative osteoarthritis of the cervical and lumbar spine. He takes extended-release oxycodone 20 mg twice a day, supplemented with immediate-release oxycodone 10 mg up to 4 times daily. The regimen has been unchanged for 8 years. Over that time, he has occasionally run out of his immediate release prescription early, which he has attributed to acute exacerbations of severe pain. He rates his pain as moderate on most days, and has variable function, is able to go on longer walks and go shopping on good days while relegated to staying at home during severe episodes. He returns for his scheduled 3-month follow-up appointment.
No reviews yet